Dramatic drug price increase leaves patients scrambling
Sodium cromoglycate is a safe, effective, no longer commonly used medication that's been around for more than 50 years. Suddenly it's become very costly for those who use it.
For patients like Robyn Fernandez, it's been a lifesaver -- literally.
"Basically, it gave me my quality of life back," the 24-year-old told CTV News Toronto. Fernandez lives with Mast Cell Activation Syndrome, an immunological condition which causes symptoms including anaphylaxis.
"It's basically your immune system is on hyper drive and overreacts to everything. And so it's sort of like when you have a superhero movie: my immune system is the superhero and whatever it decides is the super villain is the super villain and I'm the city being destroyed in the meantime."
Her explanation of the condition is lighthearted, but the effects of it are not.
"Anything can be a threat," Fernandez said, "it can just be a fabric you're wearing, it can be a scent in the air, it can be a food you're eating that used to be safe and now your body suddenly decides it's a threat. And then you can go into anaphylaxis and the next thing you know you're doing an EpiPen and you're in the hospital."
Since being diagnosed with the syndrome, Fernandez has been using sodium cromoglycate. The drug comes in nebules, which are inhaled into the lungs. In Canada, the drug is manufactured by Montreal-based Pharmascience Inc.
Earlier this year, the medication was removed from the Ontario Drug Benefit Formulary, meaning the cost is no longer covered by the province. Shortly after, those who use it found the price had gone up more than 400 per cent.
"No one's going to believe that the operating costs to make this drug suddenly soared 400 per cent," argued Dr. Matthew Stanbrook, a respirologist with the University Health Network.
"This is just an attempt to make money. It is not necessary, it is just the company trying to generate more revenue and, from a healthcare point of view, we should not have sympathy for that," Stanbrook said.
Stanbrook says the drug, which has been around since the late 1960s, was commonly used to treat conditions from asthma to allergies. But advances in medicine have led to other drugs taking its place for most patients. Still, he says, there is a small number of patients who require it.
"It holds the patients who require this hostage in a way, because they're dependant on the drug. The costs are ramped up beyond the point any individual could afford and it puts insurance companies and the third-party payers like governments in a really difficult situation."
Use of the drug has dropped more than 95 per cent in the last 15 years, according to its manufacturer. In a press release on Wednesday, Pharmascience Inc. says "the case of sodium cromoglycate illustrates well the extreme difficulty for generic pharmaceutical companies to maintain the commercialization of old generic drug products with very low utilization rates.”
The company said it is reducing the cost of the nebulizer solution to what it calls the "lowest price available in Canada".
However, even that won't help Fernandez who says the price increase makes it impossible to afford the drug. “I won't be able to take my medication anymore," she said.
The company said the cost reduction will remain in place until current inventory is depleted, providing time for physicians to find alternative therapeutics for their patients. But that may not be possible for everyone. Dr. Stanbrook calls it a "bad trade-off" that may lead to further complications for patients.
"For these few patients who depend on this, it might be trading this medication that has relatively few side-effects and is very well tolerated, for a medication that could have a lot of side-effects."
And for Fernandez, it might not be an option. She says, “There is no alternative. I talked to my pharmacy, there is no alternative. My allergist was saying we don't know what we're going to do after this because there's nothing left."
Fernandez hopes the drug will be re-added to the Ontario Drug Benefit Formulary, so she can continue to take it.
"I need it to be covered so that I can breathe and eat without going in to debt or being in a hospital all of the time."
CTVNews.ca Top Stories
DEVELOPING Man sets self on fire outside New York court where Trump trial underway
A man set himself on fire on Friday outside the New York courthouse where Donald Trump's historic hush-money trial was taking place as jury selection wrapped up, but officials said he did not appear to have been targeting Trump.
BREAKING Sask. father found guilty of withholding daughter to prevent her from getting COVID-19 vaccine
Michael Gordon Jackson, a Saskatchewan man accused of abducting his daughter to prevent her from getting a COVID-19 vaccine, has been found guilty for contravention of a custody order.
She set out to find a husband in a year. Then she matched with a guy on a dating app on the other side of the world
Scottish comedian Samantha Hannah was working on a comedy show about finding a husband when Toby Hunter came into her life. What happened next surprised them both.
Mandisa, Grammy award-winning 'American Idol' alum, dead at 47
Soulful gospel artist Mandisa, a Grammy-winning singer who got her start as a contestant on 'American Idol' in 2006, has died, according to a statement on her verified social media. She was 47.
'It could be catastrophic': Woman says natural supplement contained hidden painkiller drug
A Manitoba woman thought she found a miracle natural supplement, but said a hidden ingredient wreaked havoc on her health.
Young people 'tortured' if stolen vehicle operations fail, Montreal police tell MPs
One day after a Montreal police officer fired gunshots at a suspect in a stolen vehicle, senior officers were telling parliamentarians that organized crime groups are recruiting people as young as 15 in the city to steal cars so that they can be shipped overseas.
The Body Shop Canada explores sale as demand outpaces inventory: court filing
The Body Shop Canada is exploring a sale as it struggles to get its hands on enough inventory to keep up with "robust" sales after announcing it would file for creditor protection and close 33 stores.
Vicious attack on a dog ends with charges for northern Ont. suspect
Police in Sault Ste. Marie charged a 22-year-old man with animal cruelty following an attack on a dog Thursday morning.
On federal budget, Macklem says 'fiscal track has not changed significantly'
Bank of Canada governor Tiff Macklem says Canada's fiscal position has 'not changed significantly' following the release of the federal government's budget.